866-536-0212

Get started now

Join the fight to prevent birth defects

Cytomegalovirus (CMV) is an infection that infects between 50 & 80% of people during their lifetimes. CMV is a serious cause for concern for pregnant women.

Every year in the US, approximately 40,000 babies are born with congenital CMV. Birth defects may present immediately or may take years to develop.

You could help meet this major public health need. For babies and children across America, consider joining vaccine research studies today.

Take the next step to see if you qualify for local research studies for cytomegalovirus (CMV), a US Institute of Medicine top Tier 1 vaccine priority

Get started now

How does it work?

1

Tell us a little bit about yourself

2

Answer some questions about your health

3

We will connect you to available studies in your area

Just takes a few minutes

Get started now

COVID-19 update — we remain open.

For the safety of both staff and patients, we require that our research sites are COVID-19 SMART facilities. That means they use best practices to reduce virus exposure and are dedicated to ensuring they remain open and available for the research of investigational medications.

COVID-19 SMART steps we are taking to ensure safety include:

  • Greatly increased availability of video office visits
  • Ensuring social distancing measures are taken in all waiting areas
  • Continuing the practice of cleaning and disinfecting exams rooms thoroughly between every patient visit
  • Appropriate personal protective equipment (PPE) for all staff members at our health clinics

AcurianHealth helps connect people with research studies that offer treatment under development. Since 1998, AcurianHealth has referred 1 million study candidates to 800 studies in 70 countries.

Terms of Use | Privacy Policy